STATE STREET CORP - CYCLO THERAPEUTICS INC ownership

CYCLO THERAPEUTICS INC's ticker is CYTH and the CUSIP is 23254X201. A total of 14 filers reported holding CYCLO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of CYCLO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$45,724
+1.6%
32,200
+13.8%
0.00%
Q2 2023$44,997
+89.1%
28,3000.0%0.00%
Q1 2023$23,800
-70.4%
28,300
-50.0%
0.00%
Q4 2022$80,372
+46.1%
56,600
+100.0%
0.00%
Q3 2022$55,000
-3.5%
28,3000.0%0.00%
Q2 2022$57,000
-36.7%
28,3000.0%0.00%
Q1 2022$90,000
-15.1%
28,3000.0%0.00%
Q4 2021$106,000
-47.0%
28,300
-4.4%
0.00%
Q3 2021$200,000
-56.2%
29,600
-33.8%
0.00%
Q2 2021$457,00044,7000.00%
Other shareholders
CYCLO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Renaissance Technologies 75,787$240,0000.00%
ROYAL BANK OF CANADA 746$2,0000.00%
VANGUARD GROUP INC 255,065$808,0000.00%
UBS Group AG 2,291$7,0000.00%
IFP Advisors, Inc 26$2,0000.00%
WELLS FARGO & COMPANY/MN 2,047$6,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 48,316$153,0000.00%
STATE STREET CORP 28,300$90,0000.00%
CITIGROUP INC 1,232$4,0000.00%
View complete list of CYCLO THERAPEUTICS INC shareholders